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Abstract. A pioneering study is presented demonstrating that the pres-
ence of high glycated haemoglobin (HbA1c) levels in a patients blood can
be reliably predicted from routinely collected clinical data. This paves the
way for performing early detection of Type-2 Diabetes Mellitus (T2DM).
This will save healthcare providers a major cost associated with the ad-
ministration and assessment of clinical tests for HbA1c. A novel collabo-
rative denoising autoencoder framework is used to address this challenge.
The framework builds an independent denoising autoencoder model for
the high and low HbA1c level, which extracts feature representations
in the latent space. A baseline model using just three features: patient
age together with triglycerides and glucose level achieves 76% F1-score
with an SVM classifier. The collaborative denoising autoencoder uses 78
features and can predict HbA1c level with 81% F1-score.
Keywords: Healthcare, Machine Learning, Deep Learning, Collabora-
tive Denoising Autoencoder, Clinical Data, Diabetes, Type-2 Diabetes
Mellitus, Glycated Haemoglobin, HbA1c, KAIMRC dataset.
1 Introduction
The haemoglobin when joined with the glucose within the blood, it forms gly-
cated haemoglobin, referred to as HbA1c [30] [24]. Glycated haemoglobin (HbA1c)
is the basis for one of the important blood tests used to indicate the status of
glucose levels in the blood [30, 24].
The level of HbA1c is strongly related to the average glucose concentration
in the blood and the life span of the red blood cells. The normal red blood cells
of the human body can last for two to three months before being reproduced.
Hence the level of HbA1c can indicate the average level of blood glucose over
the whole period of the life span of the red blood cells [25, 31]. This can provide
physicians with an important long-term measure for blood glucose levels [1].
The traditional method of measuring the blood glucose levels is by using
the fasting plasma glucose (FPG) test. The FPG test can provide a measure of
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short-term blood glucose level but requires the patients to undertake an overnight
fasting prior to the test. However, the HbA1c blood test can provide an overall
average of the blood glucose level over the preceding two to three months (long-
term) and can be taken without the patient having to fast the night before the
test. Thus, HbA1c test is an attractive option for both patients and practitioners
for measuring glucose levels in the blood [1]. Recent studies have showed that
HbA1c test can be used as indicator for diagnosing diabetes (T2DM) especially
when combined with vital signs such as Body Mass Index (BMI) [15, 21].
The International Expert Committee (IEC), with members from the Amer-
ican Diabetes Association (ADA), the European Association for the Study of
Diabetes, and the International Diabetes Federation [11, 6], recommends HbA1c
test to evaluate the adults with a high risk of diabetes [1]. HbA1c levels are also
related to chronic complications [10]. The IEC recommends effective clinical in-
tervention for those patients with a HbA1c level of 6.5% or more.
Non-diabetic people with an elevated HbA1c level are also at an increased
risk of cardiovascular disease [23, 1]. The HbA1c test helps with predicting which
patients are likely to develop T2DM in the future [12]. It also helps physicians
decide how frequently patients need to undertake clinical screening for T2DM
[12]. The earlier the diagnosis of T2DM, the better chance there is of delaying
(and possibly preventing) long-term complications [13].
Research has shown that reducing the HbA1c level can significantly reduce
the possibility of developing serious complications for diabetic patients. Lowering
the HbA1c level by 1% for diabetic patients can help reduce the risk of developing
heart failure by 16%, cataracts by 19%, retinopathy and kidney disease by 25%
and death caused by vascular diseases by 43% [34, 18]. Hence, a close monitoring
of HbA1c levels is recommended for diabetic patients and also for those with
potential for developing diabetes [23].
In this paper, we introduce the first study that employs machine learning
models to predict the level of HbA1c using patient’s data. The study uses rou-
tinely collected data from hospital patients to predict the level of HbA1c. We
introduce a novel deep learning based framework to predict the level of HbA1c
using a significantly large and unique clinical dataset (KAIMRC dataset). Ac-
cording to the IEC classification of the test level, we formulate the risk of the
HbA1c test classification problem as a binary classification problem (patients
with less than a 6.5% HbA1c level being coded as low HbA1c, and for 6.5% or
more being coded as high HbA1c).
We suggest that the outcomes of this work should encourage more clinical
investigations of how far other lab tests may be predictable from the HbA1c
level. By predicting high and low levels of HbA1c, we also expect that this work
will help reduce the need for HbA1c clinical assessments, resulting in reducing
the cost and time needed to perform the test. Finally, and most importantly, it
will help identify patients who are at risk of developing diabetes by using their
hospital history visit records, and hence planning for preventive interventions.
To the best of our knowledge, there are no studies that have investigated the
prediction of HbA1c levels using any form of machine learning by making use
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of patient visit data. The main contributions of this paper are: I) introduces a
novel collaborative autoencoder framework; II) investigates the use of the rou-
tinely collected clinical patient data as predictors for HbA1c levels; III) presents
a unique and large dataset that contains the HbA1c level for 14,609 different
patient visits.
2 Related Work
With the help of Electronic Health Records (EHR), clinical data has developed
into an interesting frontier for machine learning research. In recent years, ma-
chine learning models have shown powerful capabilities of analysing and under-
standing complex clinical data in a variety of medical applications. Autoencoders
had several successes in diverse areas of applications, and especially recently with
the development of deep variations [2, 14]. In the medical field, autoencoders were
mainly used to analyse medical imaging data including: removing the noise [16],
data analytics [33], and outlier detection [7, 3].
From a clinical perspective, there have been several studies investigating the
trend of HbA1c levels. McCarter et al. [28] studied the association of the HbA1c
levels for T2DM patients over clinical variables. Conversely, Nathan et al. [29]
were able to demonstrate promising results for calculating clinical variables,
specifically, the average glucose level, from the HbA1c levels. Kazemi et al. [22]
added complications, such as retinopathy, to the clinical variables to analyse the
trend of the HbA1c levels. The above studies used the statistical linear model
to achieve this task and the data was mostly collected from diabetic patients.
Other work by Rose et al. [32] showed a correlation between the mean blood
glucose level and the HbA1c level. The correlation coefficients were found to
be between 0.71 to 0.86. However, the result can be significantly affected by
the time of day (before or after meals) at which the blood glucose level was
measured. A very recent study in 2018 by Wells et al. [36] discussed the use
of mathematical equations for HbA1c prediction, obtaining an accuracy of 77%
using only non-diabetic patients records.
The above studies used statistical and mathematical approaches to investi-
gate the correlation between HbA1c levels and clinical variables. However, they
did not explore the prediction power of the HbA1c levels using machine learning
techniques. Our approach investigates the use of a novel deep learning technique
to predict the HbA1c level for diabetic and non-diabetic patients using only
routinely collected clinical data.
3 Dataset
KAIMRC is one of the leading institutions in health research in the Middle East.
The KAIMRC5 dataset was collected by Ministry of National Guard Health
Affairs (NGHA) from three main national guard hospitals in Saudi Arabia6.
5 Access to the KAIMRC dataset can be obtained upon an official request to KAIMRC.
6 Western, Central and Eastern regions of Saudi Arabia.
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Table 1. Statistics of HbA1c KAIMRC Dataset
Characteristic Overall
Number of patient visits 13,317
Number of features 78
Number of different health conditions 99
Number of patient visit types 4
Number of discharge types 8
The KAIMRC dataset contains a full history of patients for the period be-
tween 2010 and 2015. In addition, it contains 41 million time-stamped lab test
readings, such as Blood Urea Nitrogin (BUN), cholesterol (Chol) and Mean Cor-
puscular Hemoglobin (MCH). It also holds time-stamped data on vital signs,
such as BMI and Hypertension. Other complementary features were also col-
lected during each visit, such as visit type (in-patient, or emergency), gender, pa-
tient age, service type (such as Cardiology, Neurology or Endocrinology), length
of stay (LOS) and discharge type[4].
Predicting the HbA1c level using only general clinical data is very challeng-
ing. There are many factors that affect HbA1c level and stability such as im-
proved diet and physical exercises. Changes in patient lifestyle is known to have
a significant effect on the level of HbA1c. Furthermore, the significant amount
of missing data in most of the medical datasets forms another major challenge.
Figure 1 demonstrates the challenge of separating the data between the two
classes: high and low level HbA1c, by visualising a two dimensional projection
of the data using t-SNE [27].
Fig. 1. Projection of the Row Data onto Two Dimensional Space Using t-SNE
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3.1 Data Pre-processing
Each patient visit is described by a set of measures. These measures are repre-
sented as episodes. Episodes contain the data of irregularly collected vital signs
and lab readings. In addition to this, the patient details and visit details (e.g.,
gender, age, visit type and service provided) are integrated into the episodes.
For a patient with an in-patients visit type, only the data for the first day was
considered. Cases with values of less than 0.1 of HbA1c are considered to be er-
roneous readings and have been excluded. This resulted in reducing the dataset
size from 14,609 down to 13,317 cases (Table 1).
Fig. 2. Classes Distribution over Patients Age, Random Glucose and Triglycerides.
We use 78 features for our analysis: gender, age, service, specialty, visit type
and 73 vital signs and lab results. Some features are collected frequently on an
hourly basis, such as vital signs. In these cases, the average value for the readings
on that day is used instead. 58% of the KAIMRC dataset is labelled as high level:
patients with a 6.5 HbA1c level or more, while the remaining 42% are labelled as
low level ( less than a 6.5). An integer encoding method was used to encode the
values of categorical features such as age and gender. Data standardization is
used to change the distribution of the features’ values so that they are centered
on 0 and a standard deviation of 1.
We measured the correlation between the HbA1c level and the 78 features
using Pearson Correlation Coefficient (PCC)[8]. The result shows positive linear
correlation for 44 features and zero or negative correlation for the remaining 34
features. There are three features, age, Triglycerides (Trig) and Random Glucose
(Glur), with correlation between 0.2 and 0.3. Figure 2 shows the class distribution
with regards to these three features.
In general, mining clinical data is made difficult by several problems such as
missing data, variety of lengths, and irregularity. For instance, the percentage
of missing values for Triglycerides and Random Glucose is 54% and 51% respec-
tively. As clinical data is sensitive, we avoided using techniques to interpolate
this problem.
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4 Methods
Fig. 3. Proposed Collaborative-Denoising Autoencoders Framework
To increase the separability between the classes, high vs low HbA1c levels,
the framework generates new features from each class separately by modelling
directly the data that belongs to a given class. This is motivated by the success
of pre-training in deep learning models [35, 17], however we use a separate model
per class to reduce the within-class noise and increase between-class separability.
These two models ”collaborate” by combining their outputs together to form the
input to a third classification model.
Figure 3 demonstrates the collaborative denoising autoencoders (Col-DAE)
framework piloted here. Autoencoder1 models the low HbA1c level class, while
Autoencoder2 models the high HbA1c level class. The features of latent space
of both models are then merged and fed into the MLP classification model. The
MLP model is trained to predict the level of HbA1c. To classify a sample, we
feed it to both pre-trained autoencoder models with their outputs merged and
fed to the MLP model for prediction.
4.1 Denoising Autoencoders
Autoencoders fall under the umbrella of representative learning with deep neural
networks. The goal of an Autoencoder (AE) is to learn an abstract representation
of the data presented at its input. The input can be reconstructed from that
representation. Hence the desired output of the AE is the input itself [9, 35],
making it a completely unsupervised deep learning method.
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Given an input x the AE model tries to reconstruct it as r. An AE network
consists of an encoder h = f(x) network that transforms x from the input space
to the latent space, and a decoder network which does the opposite transforma-
tion to reconstruct the original input using the decoder function r = g(h) [26,
5]. The encoder and decoder are implemented as deep neural networks, that are
optimised simultaneously using standard stochastic gradient descent algorithms.
The AE’s main task is to minimise the reconstruction error between the
input x and the reconstructed variable r using loss functions:
L(x, g(f(x))) (1)
One of the main challenges with training an AE is over-fitting to the training
data, also known as the identity function problem [19]. This occurs when the
AE cannot extract abstract features from the input and otherwise memorises
the data. This can be avoided by reducing the number of units in the hidden
layers to be fewer than the number of input units, applying dropouts, or us-
ing regularisation. Reducing the size of the hidden layers maps the input to a
lower dimensional space (known as the latent space). This forces the network
to learn correlations among the input features. The features at the latent space
represent a transformed lower dimensional version of the input that conserves its
most important information. In addition, even with large hidden layers (larger
than the input dimension), the autoencoder can discover important features and
structures in the data.
The Denoising Autoencoder (DAE) is an extended version of the basic AE
[35]. DAE avoids learning the identity function by trying to reconstruct the input
data x from a corrupted version of it, x˜. Decoding the corrupted input requires
the network to be able to denoise the corrupted input. This pushes the model
towards capturing the important information in the data without modelling
the noise. Technically, DAE is trained by minimising the reconstruction error
between x and the decoded
x˜ : L(x, g(f(x˜))) (2)
Here deep denoising autoencoders are used to model a sequences of patient
observations as input x = (x1, x2, ...xn). Mean Squared Error (MSE) is used to






(y − r)2 (3)
4.2 Models and Experimental Setup
Our framework (Col-DAE) consists of two denoising autoencoders and one s
Multi-Layer Perceptron (MLP) model. The first DAE (Autoencoder1) models
the high HbA1c level while the second DAE (Autoencoder2) models the low
HbA1c level. Each DAE model has three hidden layers for the encoder, as shown
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in Figure 3. Prior to the encoder, an isotropic Gaussian distributed noise is added
to the input layer [35]. The number of neurons for the layers in the encoder are
90 , 120 and 130 respectively. Each DAE model consists of two hidden layers for
the decoder. The first decoding layer (90 neurons) takes the embeddings in the
latent space as an input while the output layer has the same size as the input.
Tanh activation function is used in all encoder and decoder layers.
An MLP model is used as the classification model. It consists of three dense
layers. The first merges the latent spaces from the two DAEs with 260 neurons
(130 from each DAE). The second and third layers of the MLP classification
model has 70 and 32 neurons respectifly. Relu activation function is used in
both layers and Sigmoid for the output layer used for the two classes prediction.
The DAEs (Autoencoder 1 and Autoencoder 2 in Figure 3) are pre-trained
and validated to reconstruct the input using 80% and 10% of the data respec-
tively. The remaining 10% of the data is kept as the test set. The MLP clas-
sification model is trained and validated using the training and validation sets
along with the associated HbA1c labelled levels. Each test sample is fed to both
DAEs and the embedding outputs from both DAEs are merged to form the input
vector of the MLP classification model. These tasks (pre-train the DAEs, train
the MLP and testing the Col-DAE model) are repeated 10 times using a 10-folds
cross-validation approach to ensure that all data points are included in testing
the model. The DAEs of the Col-DAE model are trained for 100 epochs using
an Adam optimiser with Mean Squared Error as the loss function. The MLP of
the Col-DAE model uses same optimiser, loss function and number of epochs for
training.
4.3 Comparative Models
We have compared our results against popular base-line models: Support Vector
Machines (SVM) and Logistic Regression (LR). We also compare our results to
deep learning approaches such as MLP and Autoencoders [26, 20]. We explored
all models with different feature sizes (using the top three correlated features,
the 44 features with positive correlation and the 78 originally collected). Because
deep learning approaches work with high dimensional data, the MLP, DAE and
Col-DAE models were not experimented using three features. For the purpose of
fair comparison, these models were employed using the same data pre-processing,
training and testing techniques used for the Col-DAE model.
In addition to the accuracy, we report F1, F1 Weighted, Recall and Precision
measures to evaluate the performance of the proposed models. The Col-DAE
model was experimented on using different combination of regularisers, activa-
tion functions, dropout rates, learning rates, and optimisers. We only report the
results with the best performance as per the reported measures.
5 Results
The performance metrics for predicting the level of HbA1c, obtained using the
compared models: SVM, LR, MLP, DAE and Col-DAE with different feature
Col-DAE for HbA1c Prediction 9
sizes, are presented in Table 2. All models show better performance when using
the 78 features despite the negative linear correlation for 34 features except
for DAE models. We report an F1-score of 73.34% and 65.63% F1-Weighted
measures for DAE. However, the DAE models show clear signs of over-fitting.
The large difference between the two measures is explained by the 79.08% recall
and 68.48% precision. This is being ascribed to biased classification behaviour.
The DAE model performs the lowest among all models.
The rest of the models (SVM, LR, MLP and Col-DAE) do not show any bias
towards any of the classes. The SVM and MLP models with 78 features achieved
competitive performance with an F1-score of 78.84% and 79.72%. However, the
SVM model achieved promising performance, using three features only, with 76%
F1-score.
Table 2. Performance of Classifiers for HbA1c Risk Prediction
Model Features Size F1-Score Accuracy F1-Weighted Recall Precision
SVM 3 0.7609 0.7172 0.7162 0.7724 0.7499
44 0.7817 0.7292 0.7239 0.8324 0.7370
78 0.7884 0.7398 0.7356 0.8322 0.7492
LR 3 0.7168 0.6526 0.6476 0.7543 0.6830
44 0.7394 0.6859 0.6832 0.7648 0.7159
78 0.7574 0.7113 0.7098 0.7733 0.7424
MLP 44 0.7857 0.7465 0.7456 0.7973 0.7752
78 0.7972 0.7588 0.7573 0.8146 0.7827
DAE 44 0.7334 0.6650 0.6563 0.7908 0.6848
78 0.7301 0.6563 0.6445 0.7985 0.6737
Col-DAE 44 0.7974 0.7626 0.7620 0.8032 0.7929
78 0.8109 0.7760 0.7751 0.8240 0.7987
Table 2 shows that the Col-DAE model using 78 features achieved better
results than the compared base-line models, with 81.09% F1-score and 77.60%
of accuracy. Figure 4 summarises the 10-folds results of the reported measures
achieved by the proposed models. Figure 4 shows small variation between the
folds and especially in F1-score which demonstrates the consistency of the Col-
DAE’s performance. The differences between the obtained F1-scores for Col-
DAE with 78 features and the comparative models are statistically significant
(p-value is 0.006 with SVM, 0.005 with LR and DAE and 0.028 with MLP).
6 Discussion and Conclusion
Our framework is trained using patient clinical data from patients visiting the
hospitals for a variety of health conditions. Despite the large number of miss-
ing values, the SVM achieved 76% F1-score using three features. The Col-DAE
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Fig. 4. Box plot of the detailed performance for the proposed models.
outperformed the base-line classifiers and achieved 81% for F1-score using 78 fea-
tures. Due to the lack of similar studies and related work using machine learning,
the accuracy achieved in this paper could not be compared to any previous work.
Hence, this forms the baseline accuracy for studies aiming at predicting of HbA1c
level in the future.
The outcome of this work is significant for enabling physicians to make pre-
ventative intervention decisions in order to successfully manage the risk of high
level HbA1c. The replication of this work using other hospital clinical datasets
can ultimately help provide improved healthcare services to patients and reduce
the cost and time needed to assess the HbA1c test. This can help identifying
patients who are at a high risk of developing T2DM, and has the potential to be
used as an early warning indicator for developing serious health complications.
We introduced here the collaborative denoising autoencoders (Col-DAE).
The framework uses denoising autoencoders to model separately the high and low
level HbA1c data. The latent spaces of both models are then merged and passed
to a MLP model for decision making. This framework was utilised for a complex
classification challenge (HbA1c level prediction from routinely collected clinical
data) and has shown very promising results. The framework presented here is a
general framework and can easily be generalised for a wide range of applications
and for multi-class problems. Future work will study the interpretation of the
used features and also investigate the impact of applying different techniques for
handling the missing data in KAIMRC dataset.
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